📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Solid Biosciences

1.1 - Company Overview

Solid Biosciences Logo

Solid Biosciences

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of gene therapy candidates and research focused on rare genetic diseases, including SGT-003 for Duchenne muscular dystrophy, SGT-501 for catecholaminergic polymorphic ventricular tachycardia, and AVB-401 for BAG3-mediated dilated cardiomyopathy.

Products and services

  • SGT-003: An investigational gene therapy candidate for Duchenne muscular dystrophy, engineered by Solid Biosciences to pursue therapeutic treatment specifically targeting DMD pathology and disease burden
  • AVB-401: A research-stage gene therapy candidate for BAG3-mediated dilated cardiomyopathy, developed to address cardiomyopathy linked to BAG3 mechanisms with intended therapeutic genetic intervention
  • SGT-501: A pipeline-stage gene therapy candidate for catecholaminergic polymorphic ventricular tachycardia (CPVT), created to treat CPVT with prospective genetic treatment for this cardiac condition

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Solid Biosciences

Focus Diagnostics Logo

Focus Diagnostics

HQ: United States Website
  • Description: Provider of molecular and immunodiagnostic products and platforms for hospitals and commercial laboratories worldwide. Offers Simplexa molecular chemistries, HerpeSelect type-specific serology, and DxSelect IFA/ELISA kits for diseases such as West Nile Virus and Rickettsia, plus Luminex LTG, LIAISON PLEX multiplexing (including Respiratory Flex Assay), and LIAISON XL/XS automated CLIA assays.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Focus Diagnostics company profile →
ActX Logo

ActX

HQ: United States Website
  • Description: Provider of genomic screening and pharmacogenomic services that help physicians personalize prescriptions, identify hereditary risks, understand carrier status, and adjust dosing based on drug-genome interactions. Offers GenoACT clinical decision support integrating genetic data into EHRs with real-time alerts, plus medical genetic interpretation of 23andMe raw data.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ActX company profile →
AltheaDx Logo

AltheaDx

HQ: United States Website
  • Description: Provider of molecular diagnostics and PCR-based services, including molecular biomarker discovery, assay development and validation, prospective/retrospective clinical trial testing, and gene expression and genotyping analysis for pre-clinical and clinical applications.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AltheaDx company profile →
Great Plains Laboratory Logo

Great Plains Laboratory

HQ: United States Website
  • Description: Provider of research-based clinical laboratory tests for nutritional and metabolic factors in chronic illnesses, including autism, AD(H)D, fibromyalgia, and gastrointestinal and neuropsychiatric disorders. Offers urine- and stool-based profiles like OAT, GI360, MycoTOX, TOXDetect, Glyphosate Test, and IgG Food MAP to assess gut health, toxins, pathogens, and food sensitivities.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Great Plains Laboratory company profile →
Celula Logo

Celula

HQ: United States Website
  • Description: Provider of diagnostic testing services.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Celula company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Solid Biosciences

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Solid Biosciences

2.2 - Growth funds investing in similar companies to Solid Biosciences

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Solid Biosciences

4.2 - Public trading comparable groups for Solid Biosciences

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Solid Biosciences

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Solid Biosciences

What does Solid Biosciences do?

Solid Biosciences is a provider of gene therapy candidates and research focused on rare genetic diseases, including SGT-003 for Duchenne muscular dystrophy, SGT-501 for catecholaminergic polymorphic ventricular tachycardia, and AVB-401 for BAG3-mediated dilated cardiomyopathy.

Who are Solid Biosciences's competitors?

Solid Biosciences's competitors and similar companies include Focus Diagnostics, ActX, AltheaDx, Great Plains Laboratory, and Celula.

Where is Solid Biosciences headquartered?

Solid Biosciences is headquartered in United States.

How many employees does Solid Biosciences have?

Solid Biosciences has 1,000 employees 🔒.

When was Solid Biosciences founded?

Solid Biosciences was founded in 2010 🔒.

What sector and industry vertical is Solid Biosciences in?

Solid Biosciences is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Solid Biosciences

Who are the top strategic acquirers in Solid Biosciences's sector and industry

Top strategic M&A buyers and acquirers in Solid Biosciences's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Solid Biosciences?

Top strategic M&A buyers groups and sectors for Solid Biosciences include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Solid Biosciences's sector and industry vertical

Which are the top PE firms investing in Solid Biosciences's sector and industry vertical?

Top PE firms investing in Solid Biosciences's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Solid Biosciences's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Solid Biosciences's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Solid Biosciences's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Solid Biosciences include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Solid Biosciences's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Solid Biosciences?

The key public trading comparables and valuation benchmarks for Solid Biosciences include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Solid Biosciences for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Solid Biosciences with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Solid Biosciences's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Solid Biosciences with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Solid Biosciences's' sector and industry vertical?

Access recent funding rounds and capital raises in Solid Biosciences's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Solid Biosciences

Launch login modal Launch register modal